Pregnant or breastfeeding women, individuals with kidney or liver disorders, and those allergic to glutathione should avoid this treatment
Granhall C, Donsmark M, Blicher TM et al (2019) Safety and pharmacokinetics of single and multiple ascending doses of the novel oral human GLP-1 analogue, oral semaglutide, in healthy subjects and subjects with type 2 diabetes
Data compression for floating-point numbers often poses a trade-off in size, precision and speed 26,27,28
27 In cases of T2D, which is a chronic condition, this mechanism can be crucial as enhanced and unregulated hepatic glucose release is a prominent pathophysiological mechanism, and controlling it can improve the prognosis of the disease to a large extent
However, putting this advice into practice is not always so simple
Khan Z et al